Search hospitals
>
Tennessee
>
Nashville
Sarah Cannon Research Institute
Claim this profile
Nashville, Tennessee 37203
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Solid Tumors
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
670 reported clinical trials
29 medical researchers
Summary
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Lung Cancer, Cancer, Solid Tumors, Breast Cancer, Pancreatic Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 385 conditions. There are 29 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Vivek Subbiah.
Area of expertise
Lung Cancer
Sarah Cannon Research Institute has run 192 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Sarah Cannon Research Institute has run 179 trials for Cancer. Some of their research focus areas include:
Top PIs
Melissa Johnson, MD
Sarah Cannon Research Institute
7 years of reported clinical research
Erika P Hamilton
Sarah Cannon Research Institute
6 years of reported clinical research
Meredith A McKean
Sarah Cannon Research Institute
2 years of reported clinical research
Vivek Subbiah
MD Anderson Cancer Center
4 years of reported clinical research
Clinical Trials running at Sarah Cannon Research Institute
Breast Cancer
Lung Cancer
Solid Tumors
Ovarian Cancer
Cancer
Pancreatic Cancer
Endometrial Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Esophageal Cancer
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
Ribociclib + Hormone Therapy
for Breast Cancer
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Recruiting
2 awards
Phase 3
4 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarah Cannon Research Institute?
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Lung Cancer, Cancer, Solid Tumors, Breast Cancer, Pancreatic Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 385 conditions. There are 29 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Vivek Subbiah.
Where is Sarah Cannon Research Institute located?
The Sarah Cannon Research Institute is located at 1100 Dr Martin L King Jr Blvd Ste 800, Nashville, TN. For driving directions, please use 250 25th Ave North, Nashville, TN as your destination.
Who should I call to ask about financial aid or insurance network?
For patient inquiries, contact the Sarah Cannon Research Institute at 615-342-1000. For specific financial concerns, reach out to Patient Account Services at 615-886-4733. The "askSARAH" service on their website also addresses frequently asked questions, including financial assistance topics.
What insurance does Sarah Cannon Research Institute accept?
Sarah Cannon Research Institute is a premier oncology research organization within HCA Healthcare. HCA Healthcare hospitals, including those affiliated with Sarah Cannon, accept most major health insurance plans in the Kansas City area. It is crucial to confirm that both the specific facility and your doctor accept your insurance plan before your visit.
What awards or recognition has Sarah Cannon Research Institute received?
Sarah Cannon Research Institute (SCRI) in Nashville, Tennessee, is a recognized strategic site and was named Clinical Trial Participation Award Recipient in 2015. SCRI has conducted over 600 first-in-human clinical trials. It has contributed to the majority of new cancer therapies approved by the FDA since its inception.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.